Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1086 of 5804
-
New growth hormone injection aims to help short children grow taller
Disease control Not yet recruitingThis study comprises two phases: Phase Ib and Phase II. Phase Ib is a multicenter, randomized, open-label, active-controlled, single-dose, dose-escalation study to evaluate the safety, tolerability, PK/PD profile, and immunogenicity of a single subcutaneous dose of GenSci134 in c…
Phase: PHASE1, PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New Long-Acting growth hormone shot could mean fewer needles for kids
Disease control Not yet recruitingThis study comprises two phases: Phase Ib and Phase II. Phase Ib is a multicenter, randomized, open-label, active-controlled, single-dose, dose-escalation to assess safety, tolerability, PK/PD profile, and immunogenicity of GenSci134 in children with GHD. Phase II is a multicent…
Phase: PHASE1, PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Anti-Inflammatory drug may boost chemo for aggressive lymphoma
Disease control Recruiting nowTo evaluate the efficacy of celecoxib combined with R-CHOP versus R-CHOP in the treatment of newly diagnosed advanced CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL).The primary endpoint is Complete Response Rate (CRR)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New study aims to find safer bypass method for major aortic surgery
Disease control Recruiting nowThe study is a multicenter, two-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 236 participants diagnosed with TAAA from 4 hospitals in China. All patients receive TAAAR procedure and are randomized to control group (LHB) and experimental group (fCP…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New shot aims to cut COPD attacks in half?
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of RC1416 injection in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
One-Time iron infusion could boost recovery in elderly heart patients
Symptom relief Recruiting nowThe goal of this phase IV, open-label, randomized clinical trial is to evaluate whether intravenous iron improves quality of life in adults aged 65 years and older with iron deficiency after an acute coronary syndrome (ACS). The main questions it aims to answer are: * Does intr…
Phase: PHASE4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could a diabetes pill help heal heart and kidney damage at the same time?
Disease control Recruiting nowThe overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care in hospitalized patients with heart failure associated acute kidney injury is safe and efficacious. Investigators will assess if SGLT2 inhibition improves a composite cardio…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New RA pill shows promise in early trial
Disease control Not yet recruitingThe objective of this randomized, double-blind, placebo-controlled phase II clinical trial is to investigate the safety and efficacy of QLS12010 in subjects with moderate-to-severe rheumatoid arthritis.The main questions it aims to answer are: • Efficacy and safety of QLS12010 i…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Buddy system for PTSD: peer support boosts therapy for women veterans
Symptom relief Recruiting nowPosttraumatic stress disorder (PTSD) can have significant impairment on aspects of mental well-being (MWB) including functioning, loneliness, physical health, and quality of life. There are several evidence-based treatments (EBPs) effective in treating PTSD such as Cognitive Proc…
Phase: NA • Sponsor: Boston University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New hope for painful skin ulcers: experimental drug enters human trials
Disease control Not yet recruitingThis study aims to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of SHR-1139 Injection in patients with pyoderma gangrenosum.
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New Antibody-Drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a Phase 1/2 clinical study to evaluate the safety and efficacy of SKB105 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a simple inhaler shield your heart during stent surgery?
Disease control Recruiting nowThis is an open-label, randomized, multicenter Phase II clinical study designed to evaluate the cardioprotective effect, to determine the optimal dosages and duration of inhalation, and to assess the clinical safety of the medicinal product Aroxxen® in patients undergoing electiv…
Phase: PHASE2 • Sponsor: Research Institute of Geroprotective Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Brain scans may reveal which kids with ADHD benefit from stimulants
Knowledge-focused Recruiting nowImpulsive Aggression and chronic irritability (IACI) often occur together and are one of the most common reasons children present for behavioral health (BH) care. ADHD frequently associated with IACI as upwards of 50% of youth with ADHD manifest impairing IACI levels. IACI is the…
Phase: PHASE4 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Could a gentle zap to the ear ease stubborn back pain?
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether auricular vagus nerve stimulation using the VIVO® device can improve function and reduce pain in adults with high-impact chronic low back pain when added to standard medical care. It will also assess the safety and usability …
Phase: NA • Sponsor: Algemeen Ziekenhuis Maria Middelares • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can eye movement therapy heal earthquake trauma? new trial aims to find out
Symptom relief Not yet recruitingThis study will examine the effects of Eye Movement Desensitization and Reprocessing (EMDR) group therapy on adults who experienced the April 2025 Silivri earthquake in Turkey. Participants will be randomly assigned to either an EMDR intervention group or a waitlist control group…
Phase: NA • Sponsor: Istanbul Galata University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can a smartphone app help end HIV in young gay men?
Disease control ENROLLING_BY_INVITATIONThe Resilient HIV Implementation Science with SGM Youths using Evidence (RISE) Clinical Research Center will use a Type 2 hybrid-effectiveness-implementation study to evaluate the effectiveness and implementation of HMP, a youth-tailored digital health platform. It is hypothesize…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a diabetes drug help fight sarcoma? new trial explores metformin's potential
Disease control Recruiting nowThe purpose of this research study is to see how metformin, when used in combination with standard of care (SOC) treatment for metastatic (cancer that has spread) soft tissue sarcoma can improve patient outcomes.
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New ALS drug trial hopes to slow nerve damage
Disease control Recruiting nowThe purpose of this trial is to learn about the effects of NB-4746 compared with placebo in people with amyotrophic lateral sclerosis. The questions this trial aims to answer in comparing NB-4746 to placebo are: * What adverse events associated with taking NB-4746 are reported …
Phase: PHASE1, PHASE2 • Sponsor: Nura Bio • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for advanced cancer: experimental drug HMPL-A580 enters human trials
Disease control Recruiting nowThis is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a new drug help myasthenia gravis patients ditch steroids?
Disease control Recruiting nowThis is a prospective, multicenter single arm study designed to evaluate the effectiveness and safety of a predefined oral corticosteroids (OCS) tapering schedule to reduce OCS use in adult participants with acetylcholine receptor positive (AChR+) generalized myasthenia gravis (g…
Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC